| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF787 ZNF512B ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 SKI ADNP ZNF454 MYRF ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 6.43e-33 | 1412 | 82 | 47 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF512B ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 SKI ADNP ZNF454 ZNF564 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF44 ZNF563 | 7.86e-30 | 1459 | 82 | 45 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZSCAN21 ZNF460 ZNF253 ZNF500 ZNF813 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 SKI ZNF454 ZNF564 ZNF768 ZNF181 ZNF461 ZNF546 ZNF121 | 4.17e-21 | 1244 | 82 | 35 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZSCAN21 ZNF460 ZNF253 ZNF500 ZNF813 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 SKI ZNF454 ZNF564 ZNF768 ZNF181 ZNF461 ZNF546 ZNF121 | 8.36e-21 | 1271 | 82 | 35 | GO:0000987 |
| GeneOntologyMolecularFunction | tumor necrosis factor receptor activity | 1.43e-05 | 12 | 82 | 3 | GO:0005031 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | ZNF668 ZNF594 ZNF845 ZNF600 ZNF605 ZBTB17 ZSCAN21 ZNF808 ZSCAN2 ZNF229 ZNF292 | 1.77e-05 | 560 | 82 | 11 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | ZNF668 ZNF594 ZNF845 ZNF600 ZNF605 ZBTB17 ZSCAN21 ZNF808 ZSCAN2 ZNF229 ZNF292 | 1.95e-05 | 566 | 82 | 11 | GO:0001216 |
| GeneOntologyMolecularFunction | death receptor activity | 8.42e-05 | 21 | 82 | 3 | GO:0005035 | |
| GeneOntologyMolecularFunction | histone H3K36 dimethyltransferase activity | 9.94e-05 | 4 | 82 | 2 | GO:0140954 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 2.26e-04 | 29 | 82 | 3 | GO:0045499 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.26e-03 | 13 | 82 | 2 | GO:0046975 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF787 ZNF512B CBLL1 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF831 ADNP ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 1.77e-51 | 775 | 82 | 52 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF787 ZNF512B CBLL1 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF831 ADNP ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 2.02e-51 | 777 | 82 | 52 | PS00028 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF787 CBLL1 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF229 ZNF831 ADNP ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 1.10e-50 | 694 | 82 | 50 | IPR013087 |
| Domain | ZnF_C2H2 | ZNF787 ZNF512B CBLL1 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF831 ADNP ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 1.57e-50 | 808 | 82 | 52 | SM00355 |
| Domain | - | ZNF787 CBLL1 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF229 ZNF831 ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 1.57e-49 | 679 | 82 | 49 | 3.30.160.60 |
| Domain | Znf_C2H2-like | ZNF787 ZNF512B CBLL1 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF229 ZNF831 ADNP ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 2.89e-49 | 796 | 82 | 51 | IPR015880 |
| Domain | zf-C2H2 | ZNF787 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ADNP ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 4.31e-49 | 693 | 82 | 49 | PF00096 |
| Domain | Znf_C2H2 | ZNF787 ZNF512B ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF831 ADNP ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 5.15e-49 | 805 | 82 | 51 | IPR007087 |
| Domain | KRAB | ZNF12 ZNF34 ZNF765 ZNF263 ZNF610 ZNF845 ZNF605 ZSCAN20 ZNF577 ZNF394 ZNF550 ZNF155 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF454 ZNF564 ZNF282 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF44 ZNF563 | 3.40e-38 | 369 | 82 | 35 | SM00349 |
| Domain | KRAB | ZNF12 ZNF34 ZNF765 ZNF263 ZNF610 ZNF845 ZNF605 ZSCAN20 ZNF577 ZNF394 ZNF550 ZNF155 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF454 ZNF564 ZNF282 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF44 ZNF563 | 3.75e-38 | 370 | 82 | 35 | IPR001909 |
| Domain | KRAB | ZNF12 ZNF34 ZNF765 ZNF263 ZNF610 ZNF845 ZNF605 ZNF577 ZNF394 ZNF550 ZNF155 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF454 ZNF564 ZNF282 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF44 ZNF563 | 4.74e-37 | 358 | 82 | 34 | PS50805 |
| Domain | KRAB | ZNF12 ZNF34 ZNF765 ZNF263 ZNF610 ZNF845 ZNF605 ZNF577 ZNF394 ZNF550 ZNF155 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF454 ZNF564 ZNF282 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF44 ZNF563 | 4.74e-37 | 358 | 82 | 34 | PF01352 |
| Domain | zf-C2H2_6 | ZNF787 ZNF12 ZNF765 ZNF668 ZNF845 ZNF600 ZNF605 ZNF155 ZNF253 ZNF500 ZNF813 ZNF69 ZNF808 ZSCAN2 ZNF701 ZNF761 ZNF229 ZNF564 ZNF282 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF44 | 5.35e-25 | 314 | 82 | 25 | PF13912 |
| Domain | SCAN | 1.62e-07 | 56 | 82 | 6 | SM00431 | |
| Domain | SCAN_BOX | 2.01e-07 | 58 | 82 | 6 | PS50804 | |
| Domain | SCAN | 2.01e-07 | 58 | 82 | 6 | PF02023 | |
| Domain | SCAN_dom | 2.01e-07 | 58 | 82 | 6 | IPR003309 | |
| Domain | Retrov_capsid_C | 2.23e-07 | 59 | 82 | 6 | IPR008916 | |
| Domain | PINCH | 5.70e-05 | 3 | 82 | 2 | IPR017351 | |
| Domain | TNFR_c6 | 1.18e-04 | 22 | 82 | 3 | PF00020 | |
| Domain | TNFR | 1.97e-04 | 26 | 82 | 3 | SM00208 | |
| Domain | EGF_CA | 2.00e-04 | 122 | 82 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.16e-04 | 124 | 82 | 5 | IPR001881 | |
| Domain | hEGF | 2.47e-04 | 28 | 82 | 3 | PF12661 | |
| Domain | TNFR_NGFR_1 | 2.74e-04 | 29 | 82 | 3 | PS00652 | |
| Domain | TNFR_NGFR_2 | 2.74e-04 | 29 | 82 | 3 | PS50050 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 4.05e-04 | 33 | 82 | 3 | IPR001368 | |
| Domain | EGF_Ca-bd_CS | 8.77e-04 | 97 | 82 | 4 | IPR018097 | |
| Domain | EGF_CA | 9.47e-04 | 99 | 82 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 9.83e-04 | 100 | 82 | 4 | PS00010 | |
| Domain | Laminin_G_1 | 1.02e-03 | 11 | 82 | 2 | PF00054 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.22e-03 | 106 | 82 | 4 | IPR000152 | |
| Domain | Post-SET_dom | 2.20e-03 | 16 | 82 | 2 | IPR003616 | |
| Domain | PostSET | 2.20e-03 | 16 | 82 | 2 | SM00508 | |
| Domain | POST_SET | 2.20e-03 | 16 | 82 | 2 | PS50868 | |
| Domain | EGF | 2.30e-03 | 126 | 82 | 4 | PF00008 | |
| Domain | VWC_out | 3.10e-03 | 19 | 82 | 2 | SM00215 | |
| Domain | Semaphorin | 3.44e-03 | 20 | 82 | 2 | IPR027231 | |
| Domain | LIM | 3.47e-03 | 69 | 82 | 3 | PF00412 | |
| Domain | - | 3.61e-03 | 70 | 82 | 3 | 2.10.110.10 | |
| Domain | EGF_3 | 3.76e-03 | 235 | 82 | 5 | PS50026 | |
| Domain | EGF | 3.76e-03 | 235 | 82 | 5 | SM00181 | |
| Domain | LIM_DOMAIN_2 | 3.76e-03 | 71 | 82 | 3 | PS50023 | |
| Domain | Znf_LIM | 3.76e-03 | 71 | 82 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 3.76e-03 | 71 | 82 | 3 | PS00478 | |
| Domain | LIM | 3.76e-03 | 71 | 82 | 3 | SM00132 | |
| Domain | Quino_amine_DH_bsu | 4.15e-03 | 22 | 82 | 2 | IPR011044 | |
| Domain | EGF-like_dom | 4.80e-03 | 249 | 82 | 5 | IPR000742 | |
| Domain | Growth_fac_rcpt_ | 4.94e-03 | 156 | 82 | 4 | IPR009030 | |
| Domain | EGF_1 | 5.30e-03 | 255 | 82 | 5 | PS00022 | |
| Domain | EGF-like_CS | 5.84e-03 | 261 | 82 | 5 | IPR013032 | |
| Domain | EGF_2 | 6.22e-03 | 265 | 82 | 5 | PS01186 | |
| Domain | EGF_CA | 6.42e-03 | 86 | 82 | 3 | PF07645 | |
| Domain | SEMA | 8.15e-03 | 31 | 82 | 2 | PS51004 | |
| Domain | Sema | 8.15e-03 | 31 | 82 | 2 | SM00630 | |
| Domain | Semap_dom | 8.15e-03 | 31 | 82 | 2 | IPR001627 | |
| Domain | Sema | 8.15e-03 | 31 | 82 | 2 | PF01403 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | CCNG1 ZNF12 ZNF34 ZNF668 ZNF263 ZNF138 ZNF610 ZNF600 ZNF775 ZNF605 ZNF577 ZNF394 ZNF550 ZNF155 ZNF460 ZNF253 ZNF596 JAG1 ZNF500 ZNF343 ZNF701 ZNF470 ZNF761 SKI ZNF454 ZNF564 ZNF282 ZNF529 ZNF443 NOTCH3 ZNF461 ZNF546 ZNF563 | 5.10e-18 | 1387 | 61 | 33 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | CCNG1 ZNF12 ZNF263 ZNF610 ZNF845 ZNF775 ZNF605 ZNF394 ZNF808 SKI ZNF454 ZNF282 NOTCH3 ZNF44 ZNF563 | 6.48e-07 | 768 | 61 | 15 | MM14851 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | CCNG1 ZNF12 ZNF263 ZNF610 ZNF845 ZNF775 ZNF605 ZNF394 ZNF808 SKI ZNF454 ZNF282 NOTCH3 ZNF44 ZNF563 | 2.16e-05 | 1022 | 61 | 15 | MM15436 |
| Pubmed | ZNF34 ZNF845 ZNF550 ZNF460 ZNF253 ZNF813 ZNF701 ZNF229 ZNF564 ZNF529 ZNF181 ZNF121 ZNF44 ZNF563 | 1.04e-17 | 181 | 82 | 14 | 37372979 | |
| Pubmed | 1.67e-07 | 21 | 82 | 4 | 7865130 | ||
| Pubmed | 2.03e-07 | 22 | 82 | 4 | 31403225 | ||
| Pubmed | ZNF668 ZNF263 ZNF610 LIMS1 ZNF775 ZSCAN20 ZNF394 ZBTB17 ZSCAN21 ZNF282 ZNF292 LIMS2 | 4.26e-07 | 808 | 82 | 12 | 20412781 | |
| Pubmed | 4.51e-06 | 14 | 82 | 3 | 14757642 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 14714274 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 25368251 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 29610298 | ||
| Pubmed | Signaling via PINCH: Functions, binding partners and implications in human diseases. | 5.49e-06 | 2 | 82 | 2 | 27590440 | |
| Pubmed | Jagged-1 and Notch3 juxtacrine loop regulates ovarian tumor growth and adhesion. | 5.49e-06 | 2 | 82 | 2 | 18632624 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 30591475 | ||
| Pubmed | Jagged1/Notch3 Signaling Modulates Hemangioma-Derived Pericyte Proliferation and Maturation. | 5.49e-06 | 2 | 82 | 2 | 27941324 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 28625320 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 15004467 | ||
| Pubmed | Focal adhesion proteins Pinch1 and Pinch2 regulate bone homeostasis in mice. | 5.49e-06 | 2 | 82 | 2 | 31723057 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 22204979 | ||
| Pubmed | LIM domain proteins Pinch1/2 regulate chondrogenesis and bone mass in mice. | 5.49e-06 | 2 | 82 | 2 | 33083097 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 19150886 | ||
| Pubmed | Notch3/Jagged1 circuitry reinforces notch signaling and sustains T-ALL. | 5.49e-06 | 2 | 82 | 2 | 25499214 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 36385586 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 24138322 | ||
| Pubmed | Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. | 5.49e-06 | 2 | 82 | 2 | 24058607 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 28476798 | ||
| Pubmed | 8.39e-06 | 17 | 82 | 3 | 7557990 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | ZNF12 ZSCAN20 ZBTB17 NSD2 ZSCAN2 SKI ADNP MYRF ZNF282 ZNF181 ZNF44 | 9.35e-06 | 908 | 82 | 11 | 19274049 |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 12167643 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 30502484 | ||
| Pubmed | Brief research report: Effects of Pinch deficiency on cartilage homeostasis in adult mice. | 1.64e-05 | 3 | 82 | 2 | 36743414 | |
| Pubmed | Targeted genome modification in mice using zinc-finger nucleases. | 1.64e-05 | 3 | 82 | 2 | 20628038 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 16317048 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 8923452 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 12482954 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 33621919 | ||
| Pubmed | 1.88e-05 | 22 | 82 | 3 | 15301860 | ||
| Pubmed | 1.88e-05 | 22 | 82 | 3 | 1505991 | ||
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 2.47e-05 | 24 | 82 | 3 | 26552887 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | CBLL1 ZNF12 ZNF765 ZNF668 ZNF263 ZNF845 ZNF460 ZNF813 ZNF808 ZNF275 REPIN1 ZNF768 | 2.47e-05 | 1203 | 82 | 12 | 29180619 |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 11331308 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 19147503 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 18060036 | ||
| Pubmed | Association analysis of Notch pathway signalling genes in diabetic nephropathy. | 3.28e-05 | 4 | 82 | 2 | 21103979 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 10551863 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 28045060 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 20819128 | ||
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 3.28e-05 | 4 | 82 | 2 | 20040020 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 21283129 | ||
| Pubmed | 3.97e-05 | 28 | 82 | 3 | 18617019 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | ZNF512B ZNF12 ZNF263 ZSCAN21 ZSCAN2 ZNF275 SKI FHL2 ZNF768 ZNF292 | 4.10e-05 | 877 | 82 | 10 | 20211142 |
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 5.41e-05 | 31 | 82 | 3 | 2288909 | |
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 5.47e-05 | 5 | 82 | 2 | 11006133 | |
| Pubmed | Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II. | 5.47e-05 | 5 | 82 | 2 | 20512151 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 15882997 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 22000108 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 5.47e-05 | 5 | 82 | 2 | 15064243 | |
| Pubmed | Dissecting integrin-dependent regulation of neural stem cell proliferation in the adult brain. | 5.47e-05 | 5 | 82 | 2 | 24719101 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 21602525 | ||
| Pubmed | FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. | 5.47e-05 | 5 | 82 | 2 | 16184196 | |
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 20554499 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 17822320 | ||
| Pubmed | PINCH2 is a new five LIM domain protein, homologous to PINCHand localized to focal adhesions. | 8.19e-05 | 6 | 82 | 2 | 12651156 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 8.19e-05 | 6 | 82 | 2 | 19603167 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 24788939 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 8.19e-05 | 6 | 82 | 2 | 12244553 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 22526456 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 9108364 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 9.54e-05 | 608 | 82 | 8 | 36089195 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.14e-04 | 7 | 82 | 2 | 24711412 | |
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 10383933 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 10079256 | ||
| Pubmed | Impaired expression of Notch signaling genes in aged human skeletal muscle. | 1.14e-04 | 7 | 82 | 2 | 17301032 | |
| Pubmed | Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. | 1.14e-04 | 7 | 82 | 2 | 11344305 | |
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.14e-04 | 7 | 82 | 2 | 12846471 | |
| Pubmed | 1.36e-04 | 42 | 82 | 3 | 34673265 | ||
| Pubmed | 1.51e-04 | 832 | 82 | 9 | 36724073 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 1.52e-04 | 8 | 82 | 2 | 22652674 | |
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.52e-04 | 8 | 82 | 2 | 12242716 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 1.52e-04 | 8 | 82 | 2 | 15465493 | |
| Pubmed | Genomewide association study of movement-related adverse antipsychotic effects. | 1.52e-04 | 8 | 82 | 2 | 19875103 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 23658024 | ||
| Pubmed | Characterization of a mouse multigene family that encodes zinc finger structures. | 1.52e-04 | 8 | 82 | 2 | 2452975 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 9858718 | ||
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 22156581 | ||
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 11044610 | ||
| Pubmed | 1.90e-04 | 47 | 82 | 3 | 35462405 | ||
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 11118901 | ||
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 16245338 | ||
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 12122015 | ||
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 17709399 | ||
| Pubmed | Neuronal Bmal1 regulates retinal angiogenesis and neovascularization in mice. | 1.96e-04 | 9 | 82 | 2 | 35933488 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZNF512B CBLL1 ZNF668 ZNF845 ZBTB17 ZSCAN21 NSD2 SKI FHL2 ADNP ZNF768 | 2.26e-04 | 1294 | 82 | 11 | 30804502 |
| Pubmed | 2.31e-04 | 126 | 82 | 4 | 16284245 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.44e-04 | 10 | 82 | 2 | 23665443 | |
| Pubmed | Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion. | 2.44e-04 | 10 | 82 | 2 | 21068062 | |
| Pubmed | 2.44e-04 | 10 | 82 | 2 | 24015274 | ||
| Pubmed | A modifier in the 129S2/SvPasCrl genome is responsible for the viability of Notch1[12f/12f] mice. | 2.44e-04 | 10 | 82 | 2 | 31590629 | |
| Pubmed | 2.71e-04 | 709 | 82 | 8 | 22988430 | ||
| Pubmed | ZNF512B SLIT2 ZNF610 ZNF460 NSD2 SKI TEP1 REPIN1 ZNF768 ZNF461 | 2.93e-04 | 1116 | 82 | 10 | 31753913 | |
| Pubmed | 2.98e-04 | 11 | 82 | 2 | 10878608 | ||
| Pubmed | Pericytes are progenitors for coronary artery smooth muscle. | 2.98e-04 | 11 | 82 | 2 | 26479710 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 2.98e-04 | 11 | 82 | 2 | 15499562 | |
| Interaction | NOTCH2 interactions | ZNF787 SLIT2 ZNF765 ZNF668 ZNF594 ZNF263 FBLN1 ZNF775 ZBTB17 ZSCAN21 ZNF460 ZNF253 JAG1 ZNF813 ZSCAN2 ZNF761 ZNF275 REPIN1 ZNF282 ZNF768 NOTCH3 ZNF121 | 1.13e-18 | 423 | 82 | 22 | int:NOTCH2 |
| Interaction | LTBP2 interactions | ZNF12 ZNF765 ZNF594 ZNF263 ZNF775 ZSCAN21 ZNF564 REPIN1 ZNF282 ZNF768 | 1.73e-12 | 85 | 82 | 10 | int:LTBP2 |
| Interaction | TRIM28 interactions | CBLL1 ZNF12 ZNF34 ZNF765 ZNF263 ZNF845 LIMS1 ZNF600 ZNF550 ZNF460 NSD2 ZNF253 ZNF813 ELP1 ZNF808 ZNF701 ZNF761 ZNF229 SKI FHL2 ZNF564 ZNF529 ZNF443 ZNF181 ZNF121 ZNF44 ZNF563 | 1.14e-11 | 1474 | 82 | 27 | int:TRIM28 |
| Interaction | ZNF467 interactions | NUDT12 ZNF765 ZNF668 ZNF845 ZSCAN21 NSD2 ZNF813 ZNF761 ZNF768 ZNF121 | 2.92e-09 | 179 | 82 | 10 | int:ZNF467 |
| Interaction | TRIM41 interactions | ZNF263 ZNF138 ZNF550 ZSCAN21 ZNF460 ZNF343 ZNF275 ZNF564 ZNF121 | 3.08e-07 | 223 | 82 | 9 | int:TRIM41 |
| Interaction | RBAK interactions | 9.59e-07 | 81 | 82 | 6 | int:RBAK | |
| Interaction | ZKSCAN8 interactions | 1.00e-06 | 130 | 82 | 7 | int:ZKSCAN8 | |
| Interaction | ZNF397 interactions | 5.32e-06 | 62 | 82 | 5 | int:ZNF397 | |
| Interaction | ZSCAN20 interactions | 6.72e-06 | 65 | 82 | 5 | int:ZSCAN20 | |
| Interaction | ZNF513 interactions | 1.08e-05 | 34 | 82 | 4 | int:ZNF513 | |
| Interaction | FBLN5 interactions | 4.69e-05 | 159 | 82 | 6 | int:FBLN5 | |
| Interaction | ZFP37 interactions | 4.69e-05 | 49 | 82 | 4 | int:ZFP37 | |
| Interaction | ZFP62 interactions | 5.23e-05 | 99 | 82 | 5 | int:ZFP62 | |
| Interaction | ZNF667 interactions | 6.41e-05 | 53 | 82 | 4 | int:ZNF667 | |
| Interaction | ZMYM4 interactions | 7.02e-05 | 171 | 82 | 6 | int:ZMYM4 | |
| Interaction | ZNF473 interactions | 7.96e-05 | 56 | 82 | 4 | int:ZNF473 | |
| Interaction | ZNF287 interactions | 1.04e-04 | 60 | 82 | 4 | int:ZNF287 | |
| Interaction | ZNF787 interactions | 1.34e-04 | 64 | 82 | 4 | int:ZNF787 | |
| Interaction | PNMA8A interactions | 1.41e-04 | 122 | 82 | 5 | int:PNMA8A | |
| Interaction | FBLN2 interactions | 1.51e-04 | 66 | 82 | 4 | int:FBLN2 | |
| Interaction | ZSCAN10 interactions | 1.58e-04 | 26 | 82 | 3 | int:ZSCAN10 | |
| Interaction | LTBP4 interactions | 1.61e-04 | 67 | 82 | 4 | int:LTBP4 | |
| Interaction | SCAND1 interactions | 1.90e-04 | 70 | 82 | 4 | int:SCAND1 | |
| Interaction | ZNF423 interactions | 2.24e-04 | 73 | 82 | 4 | int:ZNF423 | |
| Interaction | ZNF710 interactions | 2.44e-04 | 30 | 82 | 3 | int:ZNF710 | |
| Interaction | ZFP3 interactions | 2.44e-04 | 30 | 82 | 3 | int:ZFP3 | |
| Interaction | ZBTB47 interactions | 3.05e-04 | 144 | 82 | 5 | int:ZBTB47 | |
| Interaction | ZNF382 interactions | 3.24e-04 | 33 | 82 | 3 | int:ZNF382 | |
| Interaction | LRP4 interactions | 3.34e-04 | 81 | 82 | 4 | int:LRP4 | |
| Interaction | ZSCAN22 interactions | 3.55e-04 | 34 | 82 | 3 | int:ZSCAN22 | |
| Interaction | ZNF652 interactions | 3.87e-04 | 35 | 82 | 3 | int:ZNF652 | |
| Interaction | RNF187 interactions | 4.21e-04 | 36 | 82 | 3 | int:RNF187 | |
| Interaction | ZFP28 interactions | 4.57e-04 | 37 | 82 | 3 | int:ZFP28 | |
| Interaction | MZF1 interactions | 4.57e-04 | 37 | 82 | 3 | int:MZF1 | |
| Interaction | KRTAP10-6 interactions | 4.58e-04 | 88 | 82 | 4 | int:KRTAP10-6 | |
| Interaction | ZSCAN23 interactions | 5.34e-04 | 39 | 82 | 3 | int:ZSCAN23 | |
| Interaction | ZNF761 interactions | 5.78e-04 | 9 | 82 | 2 | int:ZNF761 | |
| Interaction | GLI3 interactions | 6.88e-04 | 98 | 82 | 4 | int:GLI3 | |
| Interaction | RBM4B interactions | 6.99e-04 | 262 | 82 | 6 | int:RBM4B | |
| Interaction | ZNF24 interactions | 7.23e-04 | 174 | 82 | 5 | int:ZNF24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF787 ZNF765 ZNF610 ZNF845 ZNF600 ZNF577 ZNF550 ZNF155 CD177 ZNF460 ZNF813 ZNF808 ZNF701 ZNF470 ZNF761 ZNF229 ZNF529 ZNF181 ZNF461 ZNF546 | 2.24e-14 | 1192 | 82 | 20 | chr19q13 |
| Cytoband | 19q13.41 | 3.06e-07 | 78 | 82 | 5 | 19q13.41 | |
| Cytoband | 19p13.2 | 5.90e-05 | 229 | 82 | 5 | 19p13.2 | |
| Cytoband | 19q13.42 | 7.77e-05 | 125 | 82 | 4 | 19q13.42 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 9.16e-05 | 797 | 82 | 8 | chr19p13 | |
| Cytoband | 7q36.1 | 3.25e-04 | 74 | 82 | 3 | 7q36.1 | |
| Cytoband | 19q13.43 | 5.22e-04 | 87 | 82 | 3 | 19q13.43 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 2.95e-03 | 159 | 82 | 3 | chr7q36 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF787 ZNF12 ZNF34 ZNF765 ZNF668 ZNF594 ZNF263 ZNF138 ZNF610 ZNF845 ZNF600 ZNF775 ZNF605 ZSCAN20 ZNF577 ZNF394 ZBTB17 ZNF550 ZNF155 ZSCAN21 ZNF460 ZNF253 ZNF596 ZNF500 ZNF813 ZNF69 ZNF343 ZNF808 ZSCAN2 ZNF701 ZNF470 ZNF761 ZNF275 ZNF229 ZNF454 ZNF564 REPIN1 ZNF282 ZNF768 ZNF529 ZNF443 ZNF181 ZNF461 ZNF546 ZNF121 ZNF292 ZNF44 ZNF563 | 1.10e-49 | 718 | 73 | 48 | 28 |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 9.60e-05 | 4 | 73 | 2 | 1163 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 2.14e-04 | 29 | 73 | 3 | 782 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.91e-03 | 20 | 73 | 2 | 736 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-06 | 184 | 82 | 6 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.24e-06 | 186 | 82 | 6 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.36e-06 | 189 | 82 | 6 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.89e-06 | 200 | 82 | 6 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 1.36e-05 | 165 | 82 | 5 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.48e-05 | 168 | 82 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | IIH-CD8-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 2.06e-05 | 180 | 82 | 5 | d1a8b25115c80e5a5bd0b8244167a98250ab9778 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-05 | 185 | 82 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.35e-05 | 185 | 82 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 2.35e-05 | 185 | 82 | 5 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.41e-05 | 186 | 82 | 5 | ed9b1a784f67e8a297e2a10993a6d97df60581ac | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.41e-05 | 186 | 82 | 5 | bca5215d406f1785bf3a420201d5686071fcaca5 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-05 | 186 | 82 | 5 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.54e-05 | 188 | 82 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 188 | 82 | 5 | 3004e961d214919e08c7cd5f10c3de5cf85b35a3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.60e-05 | 189 | 82 | 5 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 2.95e-05 | 194 | 82 | 5 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-05 | 195 | 82 | 5 | 2eed0332e338d6f0dbcb399d9d36c4611d491b0a | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.25e-05 | 198 | 82 | 5 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | medial-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-05 | 200 | 82 | 5 | a9d8aa5bcf383d98a9e2eaf4b1f8466982d6b088 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.41e-05 | 200 | 82 | 5 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | medial-mesenchymal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-05 | 200 | 82 | 5 | 4f19e1e40966e27779bf77e8c170ed3ecc24353e | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-MAIT|ICU-NoSEP / Disease, condition lineage and cell class | 3.41e-05 | 200 | 82 | 5 | 4f03b5f4110ed1637ffe17cb6ff309265a3af9a8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-05 | 48 | 82 | 3 | 0b71435d798c6b25089a16b25d1d535f3c780d30 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 134 | 82 | 4 | bffd6ce8998368d4f486b64c220eab3a44ba147b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-04 | 135 | 82 | 4 | b444005987093efab3265201b3541d7941816cc2 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.61e-04 | 148 | 82 | 4 | e697a7fb037873c9b11703d1bf836a69fc276e23 | |
| ToppCell | E16.5-samps-Mesenchymal-Pericyte-pericyte_A|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.61e-04 | 148 | 82 | 4 | c87fe2373418ec0cfe37279003d1c4df4c0d0aac | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-04 | 150 | 82 | 4 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-3|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 153 | 82 | 4 | 9d64aadbb4bb28469af1d728457b431e21577429 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.17e-04 | 160 | 82 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | VE-CD8-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 2.17e-04 | 160 | 82 | 4 | 255d2a150bfe19ee3d4d34533feb9c37ce73d225 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.22e-04 | 161 | 82 | 4 | 82ed45f144a07856fe92d37426c5f92e259a03a9 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.22e-04 | 161 | 82 | 4 | 2fe77af3b41e6eacb707a64feea18f9991618173 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 2.22e-04 | 161 | 82 | 4 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-MAIT|ICU-NoSEP / Disease, Lineage and Cell Type | 2.50e-04 | 166 | 82 | 4 | d3fa2e42497201f1ca57f4f977fbaa0def950033 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 167 | 82 | 4 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 168 | 82 | 4 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 170 | 82 | 4 | c1f7f1bb8865e954bb499963d82bb51923d5d8d6 | |
| ToppCell | normal_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.80e-04 | 171 | 82 | 4 | f49dfe11ae66d82125b577c48345a13683d7bb7b | |
| ToppCell | Mild-CD4+_T_Exhausted|World / Disease group and Cell class | 2.86e-04 | 172 | 82 | 4 | efe68d9477aa873b1637ee689f298120303aa322 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-04 | 173 | 82 | 4 | f9d6e892d66f9b94e4d5beb9f5dec9b606bc868a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.92e-04 | 173 | 82 | 4 | cbd65dd5b01cc959e3ccbc89330ddd0122296ea3 | |
| ToppCell | ASK428-Immune-B_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.99e-04 | 174 | 82 | 4 | b5a7a612a515736cf3489afd0f6ad2054d54526f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-04 | 174 | 82 | 4 | 9bb8159a62640756d18ecbade3bf32bcbb7dd590 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-04 | 174 | 82 | 4 | e70cc623a3a6aceec813ed852fec0c4240561133 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.99e-04 | 174 | 82 | 4 | b6725086fe5a2b057c7c495ec63c970ac52c2580 | |
| ToppCell | Healthy_donor-Treg|World / disease group, cell group and cell class (v2) | 2.99e-04 | 174 | 82 | 4 | dc3b06420b0ad9c7060571e7bf5714e028d598bf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 176 | 82 | 4 | e9152defb4fd41267fb33c42c01fd0c683280783 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 176 | 82 | 4 | a4d269075aa0efc46fa251b379f334e50c69391d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-04 | 176 | 82 | 4 | cc6f65a7d2c622841c9d1ab3755586039d4ccc4d | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 3.12e-04 | 176 | 82 | 4 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-04 | 178 | 82 | 4 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 178 | 82 | 4 | 0290868dc990878eac5c182fe64968333bc52450 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 3.33e-04 | 179 | 82 | 4 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.33e-04 | 179 | 82 | 4 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-04 | 180 | 82 | 4 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-04 | 180 | 82 | 4 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-04 | 180 | 82 | 4 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 3.40e-04 | 180 | 82 | 4 | 51a12fbad5fa7bb12e6d616a02ff9b5141e2b063 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.40e-04 | 180 | 82 | 4 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.54e-04 | 182 | 82 | 4 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.62e-04 | 183 | 82 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_3|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-04 | 183 | 82 | 4 | 228092290dbb08785c4eda224e3ad03e99e10fab | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.62e-04 | 183 | 82 | 4 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-04 | 183 | 82 | 4 | 3cbe0175d05fd39bc430de1ef471ff2c5b56460e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.77e-04 | 185 | 82 | 4 | e34473eea3a58c041183a4f52137366cd9489495 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|IPF / Disease state, Lineage and Cell class | 3.77e-04 | 185 | 82 | 4 | 221cbd09d94cc0947d0e3c1aa14716d17cb2068d | |
| ToppCell | IPF-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 3.77e-04 | 185 | 82 | 4 | 77fbecdab10bacc005b1c7e22ca414cfecef13c1 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|COPD / Disease state, Lineage and Cell class | 3.77e-04 | 185 | 82 | 4 | 846403edd4c8f646201d519055198fc38b7ffff9 | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 3.77e-04 | 185 | 82 | 4 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.77e-04 | 185 | 82 | 4 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 186 | 82 | 4 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 186 | 82 | 4 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.85e-04 | 186 | 82 | 4 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 186 | 82 | 4 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.85e-04 | 186 | 82 | 4 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.85e-04 | 186 | 82 | 4 | 13bc41c60fd628af31899a5e8b480e06cc4781be | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-04 | 187 | 82 | 4 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 3.92e-04 | 187 | 82 | 4 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.00e-04 | 188 | 82 | 4 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.00e-04 | 188 | 82 | 4 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 189 | 82 | 4 | a5306561026e4dfcc39beeb785e5108ac595d136 | |
| ToppCell | IPF-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.09e-04 | 189 | 82 | 4 | 7a260485c2a7c743c14d048e5e480ae0a9b8e32c | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.09e-04 | 189 | 82 | 4 | 26cfe5b7e7f477f225f4e9f25f983f432f01e183 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-04 | 189 | 82 | 4 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 189 | 82 | 4 | 381058f55908f84375b54601d617389ef43ab855 | |
| ToppCell | facs-Kidney-nan-3m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 189 | 82 | 4 | 302b950a6ad578f8aeff7ea6fd15fe631225287d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-04 | 189 | 82 | 4 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-04 | 189 | 82 | 4 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.17e-04 | 190 | 82 | 4 | 2ab604d35456beba71c25511e0f819000e6642d2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.17e-04 | 190 | 82 | 4 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 190 | 82 | 4 | 7e4d80a3a7f83b6a50f1d0fe82fb6c242c39d5b0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 190 | 82 | 4 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 190 | 82 | 4 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.17e-04 | 190 | 82 | 4 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 190 | 82 | 4 | 7fec459cd2ad12c2923a03d098289337c0a4c1d3 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.17e-04 | 190 | 82 | 4 | 10b02c62e72bfea9767e3e751011436925da823e | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.25e-04 | 191 | 82 | 4 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.25e-04 | 191 | 82 | 4 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| Computational | Neighborhood of MYST2 | 1.70e-05 | 172 | 35 | 6 | GCM_MYST2 | |
| Computational | Neighborhood of UBE2N | 1.30e-04 | 154 | 35 | 5 | GCM_UBE2N | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; PC3; HT_HG-U133A | 5.09e-06 | 187 | 82 | 7 | 7402_DN | |
| Disease | corneal endothelial cell measurement | 2.06e-04 | 108 | 79 | 4 | EFO_0010079 | |
| Disease | stem Cell Growth Factor beta measurement | 1.09e-03 | 75 | 79 | 3 | EFO_0008292 | |
| Disease | Carcinoma, Pancreatic Ductal | 1.88e-03 | 24 | 79 | 2 | C0887833 | |
| Disease | pulmonary embolism | 2.04e-03 | 25 | 79 | 2 | EFO_0003827 | |
| Disease | vascular endothelial function measurement | 2.41e-03 | 99 | 79 | 3 | EFO_0803369 | |
| Disease | asphyxia neonatorum | 3.33e-03 | 32 | 79 | 2 | EFO_1000824 | |
| Disease | hippocampal CA3 volume | 4.20e-03 | 36 | 79 | 2 | EFO_0009395 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CVRDCEKYKPGVLLG | 811 | Q9H2P0 | |
| DSYICLCPLGFKGRH | 586 | Q63HQ2 | |
| CPKGTTHCYDGLLRL | 151 | Q8N6Q3 | |
| ELLHAQCLGSPCYKR | 1526 | Q9H0J4 | |
| PKHLGCVGLSCFYLA | 91 | P51959 | |
| KGELYCLPCHDKMGV | 181 | Q7Z4I7 | |
| KAYHLSCLGLGKRPF | 1261 | O96028 | |
| CRHGGKCLDLVDKYL | 591 | Q9UM47 | |
| KRYEKAIGHLSKCGP | 941 | O95163 | |
| DLCKRHYKPVCGSDG | 91 | Q8N475 | |
| VHFCDKCGLPIKIYG | 106 | Q75N03 | |
| YPGRLCGHKCENTLG | 406 | P23142 | |
| KYCPLGLLKNKHGCD | 546 | Q9NZV1 | |
| LGLPKEHAASLCRCY | 96 | Q9H0A8 | |
| PIGCDCKDLSYKDRH | 46 | Q14192 | |
| KGERVTLKCDGYHPL | 36 | Q6BAA4 | |
| KHGSCKLPGDCRCQY | 241 | P78504 | |
| KRKCPDHGLDLSTYC | 176 | Q96DX7 | |
| LGEGKLKRVLYCCPE | 171 | Q7Z6M4 | |
| ERLDHGKLRKPCYCG | 276 | Q53H47 | |
| GGYKRLCLKEDCPSL | 296 | Q9BQG2 | |
| QLPLHRCDIYGKACA | 511 | Q14563 | |
| DARELKGELYCLPCH | 171 | P48059 | |
| KGELYCLPCHDKMGV | 176 | P48059 | |
| YHECFGKCKGLLVPE | 221 | P12755 | |
| KKCGYPGHLTFECRN | 16 | Q8N9Q2 | |
| HTGEKPYPCKECGRR | 286 | Q9BWE0 | |
| CHLRLHTGEKPYKCE | 736 | Q96IR2 | |
| LLIHTGEKPYKCNEC | 391 | Q8N9Z0 | |
| IRHTGDGPYKCKVCG | 301 | Q8TBZ8 | |
| RTLLGKKPYICSDCG | 261 | Q6P1L6 | |
| IIHTGEKPYKCLECG | 216 | Q14592 | |
| RTHTGEKPYTCLKCG | 406 | Q53GI3 | |
| RLHTGEKPYKCNECG | 346 | Q86XN6 | |
| HLGDKPYGCLLCGKA | 301 | Q8TC21 | |
| AHLGDKPYRCPECGK | 551 | Q7Z7L9 | |
| THLVDRPYDCKCGKA | 326 | Q9Y5A6 | |
| RCAHCPKAYGALSKL | 141 | Q96K58 | |
| IIRTGEKPYKCAHCG | 186 | P52744 | |
| RVHTGEKPYKCLECG | 951 | P17040 | |
| KRCYGKRPGLEDTAH | 1501 | Q99973 | |
| LHTGDKPYKCSDCGR | 291 | Q9BSK1 | |
| RLHTGEKPYSCKECG | 741 | Q86UE3 | |
| HTGERPYKCPRCGKA | 311 | Q9H5H4 | |
| GGHLSKRSYCKPLDG | 1391 | O60281 | |
| QRTHTGEKPYLCGKC | 126 | Q96BV0 | |
| LCHRRLHSGEKPYKC | 751 | Q8N4W9 | |
| IHTGKRPYECIDCGK | 361 | Q6ECI4 | |
| LHSGKRPYECLECGK | 586 | Q6ECI4 | |
| CKHGKCRLSGLGQPY | 1421 | O94813 | |
| PRCDCAGDFHKKIGL | 31 | Q93038 | |
| RLHTGEKPYKCNECG | 571 | Q6ZN06 | |
| QRLHTGEKPYKCECG | 536 | Q9UJW7 | |
| KGAHLAGKYRCLLCP | 776 | Q96KM6 | |
| LHTGEKPYRCRECGK | 361 | O75346 | |
| RPHTGKKRYECKECG | 161 | Q8TA94 | |
| LIHTGEKPYKCLECG | 251 | Q7Z398 | |
| IIHTGEKPYLCDKCG | 606 | Q13105 | |
| RIHTGIKPYKCKECG | 276 | P58317 | |
| RLHTGKKPYDCKECG | 161 | Q9Y2A4 | |
| IHSGERPYKCKLCGK | 471 | Q9UC07 | |
| RKLHTGEKPYICEAC | 251 | Q12901 | |
| HTGEKPYRCGLCEKA | 406 | Q8N9F8 | |
| RIHSRGKPYLCNKCG | 231 | Q96JF6 | |
| LHSGEKPYECHRCGK | 316 | Q96JF6 | |
| KCSPGYRVKEACGEL | 56 | Q92956 | |
| LNICRLHSGEKPYKC | 426 | Q7L2R6 | |
| RIHKGEKPYECYICG | 541 | P17014 | |
| RLHTGEKPYKCNECG | 496 | Q9NV72 | |
| RIHTGKKPYECKACG | 386 | Q6P280 | |
| AGKYLCPHCGRDCLK | 141 | Q5JPB2 | |
| KPYGCPHCGKLFRRS | 291 | Q9NSD4 | |
| RPGCCAKHGLAEAYK | 366 | Q8NFY4 | |
| RLHSGEKPYKCNECG | 546 | Q6ZNG1 | |
| IKPGRTHGGIKYCDC | 131 | Q86T29 | |
| KPYECKQCGKLLSHR | 411 | P15621 | |
| HGARSKPYSCPECGK | 511 | Q9UDV7 | |
| RLHTGEKPYECKQCG | 321 | Q8TAF7 | |
| RIHTGEKPYECIKCG | 481 | Q2M3W8 | |
| THTGERPYKCLVCGK | 346 | O60304 | |
| EHLGRCCNKCEPGKY | 41 | Q9Y6Q6 | |
| LHHGEKPYRCSDCKK | 496 | Q8IZ26 | |
| IHTGERPYKCPECGK | 511 | O14978 | |
| HTGEKPYACLECGKR | 116 | Q6DD87 | |
| EGLKPLDCFYLKLHG | 421 | Q9Y2G1 |